HEALTHEQUITY, INC. 8-K

What Happened
HealthEquity, Inc. (HQY) filed an 8-K on March 30, 2026, reporting that the Board appointed William Gassen as a director effective March 26, 2026 and expanded the Board from nine to ten members. Mr. Gassen, the Chief Executive Officer of Sanford Health, will serve on HealthEquity’s Audit and Risk Committee and Talent, Compensation and Culture Committee (TCCC).

Key Details

• Appointment effective date: March 26, 2026; Board size increased to 10 members.
• Committee assignments: Audit and Risk Committee; Talent, Compensation and Culture Committee (TCCC).
• Related-party note: Sanford Health paid HealthEquity $123,923 in revenue for the fiscal year ended Jan 31, 2026, and HealthEquity expects Sanford-related revenue to exceed $120,000 in the fiscal year ending Jan 31, 2027.
• Compensation and legal: Mr. Gassen will receive the Company’s standard non‑employee director retainer and equity awards under the Non‑Employee Director Compensation Policy and will sign the Company’s standard indemnification agreement. The filing states there is no special arrangement or understanding connected to his appointment.

Why It Matters
This is a governance update that adds a health system CEO to HealthEquity’s Board and places him on key oversight committees (audit and compensation). For investors, the filing is notable because Sanford Health is a customer of HealthEquity (disclosed revenue amounts are modest but above the $120k disclosure threshold) and the appointment follows ordinary director compensation and indemnification practices. The change may affect board oversight and industry perspective but does not indicate any special compensation or contractual arrangement beyond standard policies.